Ashwagandha is one of the most talked-about herbs for everyday stress, but the marketing often runs ahead of the science. Here is a plain, honest look at what randomised trials have actually measured, and what they have not. We report the research and let you decide.
Key takeaways
- Adaptogen is a category, not a promise. The term describes herbs traditionally used to help the body cope with stress, but it is not a recognised UK health claim on its own.
- Trials have measured perceived stress and cortisol. Several randomised studies using 300 to 600 mg of KSM-66 over roughly eight weeks recorded lower perceived-stress scores and serum cortisol reductions of about 14 to 28 percent versus placebo.
- Effects build over weeks, not minutes. Ashwagandha is not reported as an acute, take-it-and-feel-calm ingredient. Most studies run for six to twelve weeks.
- Dose and form matter. The evidence base is strongest for standardised root extracts such as KSM-66, which our gummies provide at 2,500 mg per two-gummy serving.
- This is educational, not medical advice. Ashwagandha is a food supplement, not a treatment for any diagnosed condition.
What "adaptogen" actually means
The word adaptogen was coined by Soviet researchers in the mid-twentieth century to describe plants thought to help an organism resist a wide range of stressors while nudging the body back towards balance. Ashwagandha (Withania somnifera) sits in this traditional category alongside herbs like rhodiola. It is important to be clear about the status of the term. Adaptogen is a botanical and historical label, not an approved regulatory health claim in the UK or EU. So when you see it on packaging, read it as heritage and tradition rather than a proven physiological guarantee. What follows is a summary of what modern clinical research has measured, reported cautiously, because ashwagandha itself carries no authorised UK health claims.
What the trials measured on day-to-day stress
Most of the useful human data comes from small randomised, placebo-controlled trials in adults reporting ordinary, day-to-day stress rather than any diagnosed condition. The headline outcome researchers tend to track is the Perceived Stress Scale, a validated questionnaire that asks people how unpredictable and overloaded their recent weeks have felt. Across several of these trials, participants taking standardised ashwagandha root extract recorded larger falls in their perceived-stress scores than those on placebo. A number of studies also reported improvements in self-rated sleep quality and general wellbeing questionnaires measured alongside the primary outcome.
These are genuine signals, but they deserve context. The trials are typically small, often a few dozen to a couple of hundred participants, and several were funded by ingredient manufacturers. Self-reported scales are useful but subjective. The honest summary is that the direction of the evidence is fairly consistent, while the certainty is moderate rather than settled. You can read a broader overview of the ingredient in our guide to ashwagandha gummies benefits.
The cortisol question
Cortisol is the hormone people most associate with stress, and it is one of the few objective biological markers these trials have measured. In several randomised studies using 300 to 600 mg of KSM-66 daily over about eight weeks, researchers recorded reductions in morning serum cortisol of roughly 14 to 28 percent compared with placebo groups. That range is worth reading carefully. It is a measured change in a blood marker within specific study conditions, not a claim that lowering cortisol makes anyone feel a certain way, and not a claim about what our product will do for you.
A couple of caveats keep this honest. Cortisol naturally swings through the day and between individuals, so timing and study design matter a great deal. A change in a marker is also not the same as a change in how someone lives or feels. It is one piece of the picture, measured in controlled settings, and it should be read as research data rather than a personal outcome.
Why timing and consistency matter
One of the clearest themes in the literature is that ashwagandha is not an acute ingredient. Nobody in these trials took a dose and reported feeling different an hour later. The studies that recorded changes ran for six, eight or twelve weeks of daily use, which suggests any effect builds gradually. That has a practical implication. If you are trying it, consistency over several weeks reflects how it was studied far better than occasional use. We cover the practicalities separately in our guides on the best time to take ashwagandha and how long ashwagandha gummies take to work, so you know roughly what timeline the research points to.
Dose and form: why KSM-66 keeps coming up
Not all ashwagandha is the same, and the form used in a study matters as much as the milligrams. Most of the stress research uses standardised root extracts, and KSM-66 is the single most studied. It is a full-spectrum, root-only extract standardised to around 5 percent withanolides, which are the compounds researchers track. Standardisation matters because it means each batch delivers a consistent, measurable amount of the active constituents rather than a variable botanical powder. If you want the detail on why extract type changes the comparison, see KSM-66 versus standard ashwagandha.
For reference, our Ashwagandha and Lion's Mane Gummies provide 2,500 mg of KSM-66 per two-gummy daily serving. That is a higher raw amount than the 300 to 600 mg extract doses used in many of the trials cited above, which is simply a factual difference in dose, not a claim of greater benefit. The gummies are pectin-based, vegan, third-party tested and made in the UK, with 60 gummies per bottle for a 30-day supply. The serving also includes Lion's Mane, Ginkgo Biloba, magnesium, vitamin B6 and vitamin B12 as part of the wider stack.
Where the co-ingredients have approved claims
While ashwagandha carries no authorised UK health claims, two of the supporting nutrients in the formula do. Magnesium contributes to normal psychological function, and vitamin B6 contributes to normal energy-yielding metabolism. These are the only benefit statements in this article tied to approved claims, and they apply to those specific nutrients rather than to ashwagandha or to the product as a whole. It is a useful reminder that a supplement is a sum of parts, each with its own evidence status.
What ashwagandha is not
Being straight about the limits matters. Ashwagandha is a food supplement, not a medicine, and nothing here should be read as a way to treat, cure or prevent any condition. The research discussed relates to ordinary, day-to-day stress in generally healthy adults, not to clinically diagnosed conditions, which are a matter for a healthcare professional. The evidence, while broadly encouraging, is drawn from small and sometimes industry-funded trials, so it is best described as promising rather than definitive. Please speak to your GP before starting, particularly if you are pregnant or breastfeeding, taking any medication (especially thyroid medication), or managing an existing health condition. You can see the full range on our shop page.
Common questions
Does ashwagandha work instantly for stress?
The research does not point that way. The trials that measured changes in perceived stress and cortisol ran for several weeks of daily use, so the studied effect appears to build gradually rather than acutely. Consistency matches how it was tested.
How much ashwagandha did the studies use?
Many of the perceived-stress and cortisol trials used 300 to 600 mg of standardised KSM-66 extract per day over around eight weeks. For context, our gummies provide 2,500 mg of KSM-66 per two-gummy serving, which is a factual note on dose rather than a claim.
Is ashwagandha safe to take with other medication?
That is a question for your GP or pharmacist rather than an article. Ashwagandha can be relevant to people on thyroid medication in particular, so a professional who knows your history should advise before you start.
What does the cortisol reduction figure actually mean?
It describes a measured fall in morning serum cortisol of roughly 14 to 28 percent in specific placebo-controlled studies. It is a research finding about a blood marker under study conditions, not a promise about how you personally will feel.
